vs
Side-by-side financial comparison of MODIV INDUSTRIAL, INC. (MDV) and ROCKWELL MEDICAL, INC. (RMTI). Click either name above to swap in a different company.
ROCKWELL MEDICAL, INC. is the larger business by last-quarter revenue ($18.3M vs $11.1M, roughly 1.7× MODIV INDUSTRIAL, INC.). MODIV INDUSTRIAL, INC. runs the higher net margin — 11.0% vs -3.0%, a 14.0% gap on every dollar of revenue. On growth, MODIV INDUSTRIAL, INC. posted the faster year-over-year revenue change (-5.6% vs -25.6%). Over the past eight quarters, MODIV INDUSTRIAL, INC.'s revenue compounded faster (-3.8% CAGR vs -10.1%).
MODIV INDUSTRIAL, INC. is a U.S.-based industrial real estate enterprise focused on acquiring, owning and operating high-quality industrial properties mainly located in key logistics and distribution hubs across North America. It serves tenants from sectors including e-commerce fulfillment, manufacturing and third-party logistics, addressing rising demand for modern supply chain infrastructure.
Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD).
MDV vs RMTI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $11.1M | $18.3M |
| Net Profit | $1.2M | $-554.0K |
| Gross Margin | — | 21.1% |
| Operating Margin | 45.8% | -2.2% |
| Net Margin | 11.0% | -3.0% |
| Revenue YoY | -5.6% | -25.6% |
| Net Profit YoY | -22.0% | 26.7% |
| EPS (diluted) | $0.02 | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $11.1M | $18.3M | ||
| Q3 25 | $11.7M | $15.9M | ||
| Q2 25 | $11.8M | $16.1M | ||
| Q1 25 | $11.8M | $18.9M | ||
| Q4 24 | $11.7M | $24.7M | ||
| Q3 24 | $11.7M | $28.3M | ||
| Q2 24 | $11.4M | $25.8M | ||
| Q1 24 | $12.0M | $22.7M |
| Q4 25 | $1.2M | $-554.0K | ||
| Q3 25 | $1.0M | $-1.8M | ||
| Q2 25 | $-2.0M | $-1.5M | ||
| Q1 25 | $829.0K | $-1.5M | ||
| Q4 24 | $1.6M | $-756.0K | ||
| Q3 24 | $-587.0K | $1.7M | ||
| Q2 24 | $1.3M | $343.0K | ||
| Q1 24 | $3.7M | $-1.7M |
| Q4 25 | — | 21.1% | ||
| Q3 25 | — | 14.3% | ||
| Q2 25 | — | 15.6% | ||
| Q1 25 | — | 16.1% | ||
| Q4 24 | — | 14.7% | ||
| Q3 24 | — | 22.0% | ||
| Q2 24 | — | 17.6% | ||
| Q1 24 | — | 13.5% |
| Q4 25 | 45.8% | -2.2% | ||
| Q3 25 | 41.4% | -9.9% | ||
| Q2 25 | 9.8% | -8.4% | ||
| Q1 25 | 40.2% | -7.2% | ||
| Q4 24 | 45.4% | -2.1% | ||
| Q3 24 | 42.0% | 6.8% | ||
| Q2 24 | 44.6% | 2.0% | ||
| Q1 24 | 55.6% | -5.8% |
| Q4 25 | 11.0% | -3.0% | ||
| Q3 25 | 9.0% | -11.0% | ||
| Q2 25 | -17.1% | -9.3% | ||
| Q1 25 | 7.0% | -8.0% | ||
| Q4 24 | 13.3% | -3.1% | ||
| Q3 24 | -5.0% | 5.9% | ||
| Q2 24 | 11.6% | 1.3% | ||
| Q1 24 | 31.1% | -7.6% |
| Q4 25 | $0.02 | $-0.01 | ||
| Q3 25 | $0.00 | $-0.05 | ||
| Q2 25 | $-0.32 | $-0.05 | ||
| Q1 25 | $-0.01 | $-0.04 | ||
| Q4 24 | $0.07 | $-0.02 | ||
| Q3 24 | $-0.18 | $0.04 | ||
| Q2 24 | $0.03 | $0.01 | ||
| Q1 24 | $0.33 | $-0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $14.4M | $10.7M |
| Total DebtLower is stronger | $261.5M | — |
| Stockholders' EquityBook value | $162.7M | $37.0M |
| Total Assets | $476.5M | $57.1M |
| Debt / EquityLower = less leverage | 1.61× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $14.4M | $10.7M | ||
| Q3 25 | $8.3M | $13.6M | ||
| Q2 25 | $5.8M | $12.5M | ||
| Q1 25 | $6.2M | $11.4M | ||
| Q4 24 | $11.5M | $15.7M | ||
| Q3 24 | $6.8M | $12.3M | ||
| Q2 24 | $18.9M | $11.9M | ||
| Q1 24 | $18.4M | $6.6M |
| Q4 25 | $261.5M | — | ||
| Q3 25 | $279.7M | — | ||
| Q2 25 | $279.7M | — | ||
| Q1 25 | $279.7M | — | ||
| Q4 24 | $279.8M | — | ||
| Q3 24 | $279.7M | — | ||
| Q2 24 | $279.7M | — | ||
| Q1 24 | $279.6M | — |
| Q4 25 | $162.7M | $37.0M | ||
| Q3 25 | $164.8M | $37.0M | ||
| Q2 25 | $165.6M | $30.4M | ||
| Q1 25 | $171.1M | $31.5M | ||
| Q4 24 | $190.1M | $32.6M | ||
| Q3 24 | $186.3M | $29.1M | ||
| Q2 24 | $187.0M | $23.5M | ||
| Q1 24 | $188.0M | $20.6M |
| Q4 25 | $476.5M | $57.1M | ||
| Q3 25 | $499.6M | $57.5M | ||
| Q2 25 | $498.9M | $52.6M | ||
| Q1 25 | $506.8M | $54.0M | ||
| Q4 24 | $507.8M | $59.2M | ||
| Q3 24 | $507.4M | $57.1M | ||
| Q2 24 | $519.5M | $53.0M | ||
| Q1 24 | $522.5M | $50.7M |
| Q4 25 | 1.61× | — | ||
| Q3 25 | 1.70× | — | ||
| Q2 25 | 1.69× | — | ||
| Q1 25 | 1.63× | — | ||
| Q4 24 | 1.47× | — | ||
| Q3 24 | 1.50× | — | ||
| Q2 24 | 1.50× | — | ||
| Q1 24 | 1.49× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $15.0M | $2.3M |
| Free Cash FlowOCF − Capex | — | $2.2M |
| FCF MarginFCF / Revenue | — | 12.0% |
| Capex IntensityCapex / Revenue | — | 0.5% |
| Cash ConversionOCF / Net Profit | 12.34× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-1.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $15.0M | $2.3M | ||
| Q3 25 | $4.1M | $-1.3M | ||
| Q2 25 | $3.9M | $1.8M | ||
| Q1 25 | $3.0M | $-3.5M | ||
| Q4 24 | $18.2M | $865.0K | ||
| Q3 24 | $5.1M | $4.3M | ||
| Q2 24 | $4.7M | $1.4M | ||
| Q1 24 | $3.0M | $-2.4M |
| Q4 25 | — | $2.2M | ||
| Q3 25 | — | $-1.5M | ||
| Q2 25 | — | $1.7M | ||
| Q1 25 | — | $-3.5M | ||
| Q4 24 | — | $470.0K | ||
| Q3 24 | — | $4.1M | ||
| Q2 24 | — | $1.2M | ||
| Q1 24 | — | $-2.5M |
| Q4 25 | — | 12.0% | ||
| Q3 25 | — | -9.6% | ||
| Q2 25 | — | 10.5% | ||
| Q1 25 | — | -18.8% | ||
| Q4 24 | — | 1.9% | ||
| Q3 24 | — | 14.4% | ||
| Q2 24 | — | 4.5% | ||
| Q1 24 | — | -11.1% |
| Q4 25 | — | 0.5% | ||
| Q3 25 | — | 1.4% | ||
| Q2 25 | — | 1.0% | ||
| Q1 25 | — | 0.3% | ||
| Q4 24 | — | 1.6% | ||
| Q3 24 | — | 0.7% | ||
| Q2 24 | — | 1.1% | ||
| Q1 24 | — | 0.6% |
| Q4 25 | 12.34× | — | ||
| Q3 25 | 3.95× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 3.68× | — | ||
| Q4 24 | 11.72× | — | ||
| Q3 24 | — | 2.57× | ||
| Q2 24 | 3.55× | 4.20× | ||
| Q1 24 | 0.80× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MDV
Segment breakdown not available.
RMTI
| US | $15.9M | 87% |
| Non Us | $2.4M | 13% |
